104 related articles for article (PubMed ID: 16697958)
1. The PTEN and INK4A/ARF tumor suppressors maintain myelolymphoid homeostasis and cooperate to constrain histiocytic sarcoma development in humans.
Carrasco DR; Fenton T; Sukhdeo K; Protopopova M; Enos M; You MJ; Di Vizio D; Nogueira C; Stommel J; Pinkus GS; Fletcher C; Hornick JL; Cavenee WK; Furnari FB; Depinho RA
Cancer Cell; 2006 May; 9(5):379-90. PubMed ID: 16697958
[TBL] [Abstract][Full Text] [Related]
2. Preferentially different mechanisms of inactivation of 9p21 gene cluster in liver fluke-related cholangiocarcinoma.
Chinnasri P; Pairojkul C; Jearanaikoon P; Sripa B; Bhudhisawasdi V; Tantimavanich S; Limpaiboon T
Hum Pathol; 2009 Jun; 40(6):817-26. PubMed ID: 19200577
[TBL] [Abstract][Full Text] [Related]
3. The INK4a/ARF locus and melanoma.
Sharpless E; Chin L
Oncogene; 2003 May; 22(20):3092-8. PubMed ID: 12789286
[TBL] [Abstract][Full Text] [Related]
4. Both products of the mouse Ink4a/Arf locus suppress melanoma formation in vivo.
Sharpless NE; Kannan K; Xu J; Bosenberg MW; Chin L
Oncogene; 2003 Aug; 22(32):5055-9. PubMed ID: 12902988
[TBL] [Abstract][Full Text] [Related]
5. Role of INK4a locus in normal eye development and cataract genesis.
Cheong C; Sung YH; Lee J; Choi YS; Song J; Kee C; Lee HW
Mech Ageing Dev; 2006 Jul; 127(7):633-8. PubMed ID: 16620915
[TBL] [Abstract][Full Text] [Related]
6. Differential roles of p16INK4A and p14ARF genes in prognosis of oral carcinoma.
Sailasree R; Abhilash A; Sathyan KM; Nalinakumari KR; Thomas S; Kannan S
Cancer Epidemiol Biomarkers Prev; 2008 Feb; 17(2):414-20. PubMed ID: 18268126
[TBL] [Abstract][Full Text] [Related]
7. Synergism between INK4a/ARF inactivation and aberrant HGF/SF signaling in rhabdomyosarcomagenesis.
Sharp R; Recio JA; Jhappan C; Otsuka T; Liu S; Yu Y; Liu W; Anver M; Navid F; Helman LJ; DePinho RA; Merlino G
Nat Med; 2002 Nov; 8(11):1276-80. PubMed ID: 12368906
[TBL] [Abstract][Full Text] [Related]
8. Genomic instability, mutations and expression analysis of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in actinic keratosis.
Kanellou P; Zaravinos A; Zioga M; Stratigos A; Baritaki S; Soufla G; Zoras O; Spandidos DA
Cancer Lett; 2008 Jun; 264(1):145-61. PubMed ID: 18331779
[TBL] [Abstract][Full Text] [Related]
9. Induction of nevi and skin tumors in Ink4a/Arf Xpa knockout mice by neonatal, intermittent, or chronic UVB exposures.
van Schanke A; van Venrooij GM; Jongsma MJ; Banus HA; Mullenders LH; van Kranen HJ; de Gruijl FR
Cancer Res; 2006 Mar; 66(5):2608-15. PubMed ID: 16510579
[TBL] [Abstract][Full Text] [Related]
10. Molecular analysis of the Ink4a/Rb1-Arf/Tp53 pathways in radon-induced rat lung tumors.
Bastide K; Guilly MN; Bernaudin JF; Joubert C; Lectard B; Levalois C; Malfoy B; Chevillard S
Lung Cancer; 2009 Mar; 63(3):348-53. PubMed ID: 18656278
[TBL] [Abstract][Full Text] [Related]
11. Hematopoietic malignancies associated with increased Stat5 and Bcl-x(L) expressions in Ink4a/Arf-deficient mice.
Sung YH; Park J; Choi B; Kim J; Cheong C; Choi YS; Yang EY; Lee M; Han JS; Park SC; Han TH; Kim TJ; Song J; Rhee K; Lee HW
Mech Ageing Dev; 2005; 126(6-7):732-9. PubMed ID: 15888328
[TBL] [Abstract][Full Text] [Related]
12. Loss of Arf causes tumor progression of PDGFB-induced oligodendroglioma.
Tchougounova E; Kastemar M; Bråsäter D; Holland EC; Westermark B; Uhrbom L
Oncogene; 2007 Sep; 26(43):6289-96. PubMed ID: 17438529
[TBL] [Abstract][Full Text] [Related]
13. p53-Dependent and -independent functions of the Arf tumor suppressor.
Sherr CJ; Bertwistle D; DEN Besten W; Kuo ML; Sugimoto M; Tago K; Williams RT; Zindy F; Roussel MF
Cold Spring Harb Symp Quant Biol; 2005; 70():129-37. PubMed ID: 16869746
[TBL] [Abstract][Full Text] [Related]
14. ROS fusion tyrosine kinase activates a SH2 domain-containing phosphatase-2/phosphatidylinositol 3-kinase/mammalian target of rapamycin signaling axis to form glioblastoma in mice.
Charest A; Wilker EW; McLaughlin ME; Lane K; Gowda R; Coven S; McMahon K; Kovach S; Feng Y; Yaffe MB; Jacks T; Housman D
Cancer Res; 2006 Aug; 66(15):7473-81. PubMed ID: 16885344
[TBL] [Abstract][Full Text] [Related]
15. Frequent loss of the CDKN2C (p18INK4c) gene product in pituitary adenomas.
Kirsch M; Mörz M; Pinzer T; Schackert HK; Schackert G
Genes Chromosomes Cancer; 2009 Feb; 48(2):143-54. PubMed ID: 18973139
[TBL] [Abstract][Full Text] [Related]
16. Genetic analysis of Pten and Ink4a/Arf interactions in the suppression of tumorigenesis in mice.
You MJ; Castrillon DH; Bastian BC; O'Hagan RC; Bosenberg MW; Parsons R; Chin L; DePinho RA
Proc Natl Acad Sci U S A; 2002 Feb; 99(3):1455-60. PubMed ID: 11818530
[TBL] [Abstract][Full Text] [Related]
17. PTEN, more than the AKT pathway.
Blanco-Aparicio C; Renner O; Leal JF; Carnero A
Carcinogenesis; 2007 Jul; 28(7):1379-86. PubMed ID: 17341655
[TBL] [Abstract][Full Text] [Related]
18. Promoter hypermethylation of p16INK4A, p14ARF, CyclinD2 and Slit2 in serum and tumor DNA from breast cancer patients.
Sharma G; Mirza S; Prasad CP; Srivastava A; Gupta SD; Ralhan R
Life Sci; 2007 Apr; 80(20):1873-81. PubMed ID: 17383681
[TBL] [Abstract][Full Text] [Related]
19. A spatially and temporally restricted mouse model of soft tissue sarcoma.
Kirsch DG; Dinulescu DM; Miller JB; Grimm J; Santiago PM; Young NP; Nielsen GP; Quade BJ; Chaber CJ; Schultz CP; Takeuchi O; Bronson RT; Crowley D; Korsmeyer SJ; Yoon SS; Hornicek FJ; Weissleder R; Jacks T
Nat Med; 2007 Aug; 13(8):992-7. PubMed ID: 17676052
[TBL] [Abstract][Full Text] [Related]
20. Reduced expression of INK4a/ARF genes in stem-like sphere cells from rat sarcomas.
Fujii H; Honoki K; Tsujiuchi T; Kido A; Yoshitani K; Mori T; Takakura Y
Biochem Biophys Res Commun; 2007 Oct; 362(3):773-8. PubMed ID: 17761140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
